.
BioEnterprise

TheraVasc

TheraVasc is developing treatments for peripheral artery disease and diabetic neuropathy based on an oral formulation of sodium nitrite.

Funding

JumpStart, Portal Capital, North Coast Angel Fund, Ohio TechAngels, Physician Investment Group

Stage

Clinical